Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
EXTON, Pa., April 25, 2016 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc., (NASDAQ:FCSC), an autologous cell and gene therapy company focused on developing transformational therapies for diseases...
-
AMES, Iowa, April 25, 2016 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK), a biopharmaceutical company at the forefront of discovering, developing and commercializing novel...
-
SAN FRANCISCO, April 23, 2016 (GLOBE NEWSWIRE) -- One of the most common reasons that people gain weight is emotional eating. Triggered by stress, emotional eating can cause a variety of unhealthy...
-
NASHVILLE, Tenn., April 22, 2016 (GLOBE NEWSWIRE) -- Symmetry Surgical Inc. (Nasdaq:SSRG) announced today that it will release first quarter 2016 financial results for the period ending April 2,...
-
SALT LAKE CITY, April 22, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN) today announced that it will hold its fiscal third-quarter 2016 sales and earnings conference call with...
-
DALLAS and FORT WORTH, Texas, April 21, 2016 (GLOBE NEWSWIRE) -- Carter BloodCare, a blood center serving 200 medical facilities in 50-plus Texas counties, announces it is only the second blood center...
-
DEERFIELD, Ill., April 21, 2016 (GLOBE NEWSWIRE) -- Surgical Care Affiliates, Inc. (NASDAQ:SCAI) (“SCA”) will present at the Deutsche Bank 41st Annual Health Care Conference on Wednesday, May 4,...
-
GREENVILLE, S.C., April 21, 2016 (GLOBE NEWSWIRE) -- eRAD, a division of RadNet, Inc., and a leading provider of standards-based, web-centric radiology image and data management solutions,...
-
SAN FRANCISCO, CA--(Marketwired - April 21, 2016) - Solid tumors are typically managed with surgical resection, chemotherapy, radiation and biologics, but it's the secondary tumor mass, the...
-
SAN FRANCISCO, CA--(Marketwired - April 21, 2016) - To treat chronic pain without risk of addiction is to straddle a knife's edge. But Relmada Therapeutics Inc. (OTCQB: RLMD) has a small fleet...